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Osteogenesis imperfecta (OI) is a genetic disease, with a connective tissue alteration, consisting in the presence of multiple
spontaneous fractures or after minimal traumatism. Its association with other metabolic processes is rarely described. We present
the clinical case of a female adult patient of 43years. From her infancy, she has had multiple fractures, needing several surgical
interventions, and she was diagnosed of OI type 2 at adolescence age. Due mainly to diﬃculties in walking remaining in wheel-
chair in the last three years, she was overweight with morbid obesity (BMI = 45.4) and had a type-II DM associated. She suﬀered
from recurrent abdominal pain and chronic diarrhea and was diagnosed of celiac disease (CD) with increased intraepithelial
duodenal inﬁltration, being classiﬁed as lymphocytic enteritis, Marsh I type. She was put on a gluten-free diet (GFD), having lost
6 kg of weight after 6 months, with a good control of DM-II and presenting a signiﬁcant clinical improvement. It is rewarding to
search the presence of two coincidental metabolic diseases associated to OI, specially CD, because of the dramatic clinical beneﬁt
in the general found after putting on a GFD.
1.Introduction
Osteogenesis imperfecta (OI) is a genetic disease, associ-
ated with a connective tissue disorder, related to diﬀerent
phenotypic presentations. It is also called “brittle bone
disease.” Severely aﬀected patients have multiple fractures
since childhood, both spontaneous or related to minimal
trauma, and the most seriously aﬀected children usually
die in the neonatal period. Milder forms of OI may be
manifestedlateron,intheformofearlyosteoporosisorbone
mineral loss, that is more important after the menopause
[1, 2].
Its association with other metabolic processes is rarely
described. We present here the case of an adult woman with
a severe OI, diagnosed in the adolescence period and more
recently of celiac disease (CD) and type II diabetes mellitus
(DM-II), describing its evolution and changes after starting
on a gluten-free diet (GFD).
2. Case Presentation
We present the case of a 43-year-old female. Shortly after
birth, she presented a spontaneous right hip fracture. From
then, until now, she has had multiple fractures of both
arms and legs, which have required several interventions for
correction, needing on the left humerus to be ﬁxed with
a medullary locking (Figure 1). The last fracture episode
happened 3 years ago. OI type 2 was diagnosed, 20 years ago.
For moving at home, she walks with diﬃculty with a cane,
and, on the street, she is moved by wheelchair. She presents a
signiﬁcant growth delay (High = 1 14m) and weighed 65kg,
presenting a picture of morbid obesity, with an increased
body mass index (BMI = 45.4kg/m2).
She relates that for about 2 years, and she has slow
digestion, accompanied by marked abdominal bloating,
accompanied by heartburn and reﬂux. The major alteration
in her bowel habit was an alternating pattern with diarrhea2 Case Reports in Medicine
Figure 1: Intramedullary nail placed on the left humerus fracture.
and constipation. The patient had also bilateral hearing loss,
requiring hearing aids for ten years.
Currently, the CBC was normal. Blood glucose was
elevated (230mg/dL) with increased glucosuria (4+). The
rest of biochemical analysis was normal. She underwent
a gastroscopy that showed a moderate reﬂux oesophagitis
(gradeBAngelesclassiﬁcation)withoutassociatedhiatalher-
nia. Duodenal biopsies showed an increased intraepithelial
lymphocytosis (45%) corresponding to stage I of aﬀordable
Marsh. Genetic markers of CD type DQ2 were positive
in homozygosis, and antibodies to tissue transglutaminase
(tTG) were normal (0.6U/mL). Antinuclear antibodies were
negative. Vitamin D deﬁciency was excluded.
3. Intervention
She was started on a gluten-free diet (GFD) and an oral
antibiotic drug, type Metformine-850mg/twice daily was
given, having lost 6kg of weight in 6 months with good
controlofDM-IIandpresentingasigniﬁcantlyimprovement
related to the presence of prior digestive problem. A recently
completed study of bone mineral density (BMD) has been
reported as normal.
4. Discussion
The estimated incidence of OI is approximately one case per
live 20,000 births. This means that it is included within the
so-called orphan diseases as deﬁned in the USA when the
disease aﬀects fewer than 200,000 people. There are over 200
genetic mutations associated with the phenotype of OI [3].
Most OI patients have mutations that aﬀect one or both
chains of type I collagen, although up to 10% of patients do
not have them. The defect in bone quality explains many of
the clinical aspects of OI.
The most common clinical manifestations include the
presence of multiple fractures, associated by short stature,
scoliosis, deformities of the skull base, blue sclerae, hearing
loss, opalescent teeth, increased laxity of ligaments and skin,
and presence of spontaneous bruising. The frequency of
fractures decreases after the puberty [4–6]. The diagnosis
of OI is based on signs and symptoms listed above. A
positive family history is a factor of great help. However,
in the absence of these events, it can be diﬃcult to achieve.
Extraskeletal manifestations may be subclinical (deafness,
blue sclerae, or defective dentinogenesis).
Although the biochemical parameters are normal, some
alterations may be present, such as high levels of alkaline
phosphatase; the presence of hypercalciuria is common in
children, together with increased bone resorption markers
[7, 8]. Their association in adults with CD and DM-
II is poorly understood, but its diagnosis and treatment
signiﬁcantly improve the quality of life of patients and
therefore to her clinical and/or analytical, it is advisable to
perform an adequate search of these diseases, for their early
identiﬁcation and treatment [9, 10].
In conclusion, we must emphasize the convenience of
ruling out the presence of a gluten intolerance in patients
with osteogenesis imperfecta, mainly if they present a type
II diabetes mellitus associated, and the clear clinical beneﬁt
observed on a GFD, as it has been shown in the presented
case.
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